88 related articles for article (PubMed ID: 20546673)
1. Role of CCL2/MCP-1 in islet transplantation.
Melzi R; Mercalli A; Sordi V; Cantarelli E; Nano R; Maffi P; Sitia G; Guidotti LG; Secchi A; Bonifacio E; Piemonti L
Cell Transplant; 2010; 19(8):1031-46. PubMed ID: 20546673
[TBL] [Abstract][Full Text] [Related]
2. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation.
Schröppel B; Zhang N; Chen P; Chen D; Bromberg JS; Murphy B
J Am Soc Nephrol; 2005 Feb; 16(2):444-51. PubMed ID: 15601743
[TBL] [Abstract][Full Text] [Related]
3. Successful islet transplantation to two recipients from a single donor by targeting proinflammatory cytokines in mice.
Satoh M; Yasunami Y; Matsuoka N; Nakano M; Itoh T; Nitta T; Anzai K; Ono J; Taniguchi M; Ikeda S
Transplantation; 2007 Apr; 83(8):1085-92. PubMed ID: 17452899
[TBL] [Abstract][Full Text] [Related]
4. Human pancreatic islet preparations release HMGB1: (ir)relevance for graft engraftment.
Nano R; Racanicchi L; Melzi R; Mercalli A; Maffi P; Sordi V; Ling Z; Scavini M; Korsgren O; Celona B; Secchi A; Piemonti L
Cell Transplant; 2013; 22(11):2175-86. PubMed ID: 23051559
[TBL] [Abstract][Full Text] [Related]
5. In vitro modulation of monocyte chemoattractant protein-1 release in human pancreatic islets.
Marzorati S; Melzi R; Nano R; Antonioli B; Di Carlo V; Piemonti L; Bertuzzi F
Transplant Proc; 2004 Apr; 36(3):607-8. PubMed ID: 15110609
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
7. The source matters: no impact of the CCL2/MCP-1-1-2518G polymorphism of the donor on renal allograft outcome during the first year after transplantation.
Lehmann I; Fischereder M; Böhmig GA; Regele H; Exner M; Raith M; Weiss N; Segerer S
Transplant Proc; 2008 Dec; 40(10):3359-61. PubMed ID: 19100389
[TBL] [Abstract][Full Text] [Related]
8. Human islets express a marked proinflammatory molecular signature prior to transplantation.
Cowley MJ; Weinberg A; Zammit NW; Walters SN; Hawthorne WJ; Loudovaris T; Thomas H; Kay T; Gunton JE; Alexander SI; Kaplan W; Chapman J; O'Connell PJ; Grey ST
Cell Transplant; 2012; 21(9):2063-78. PubMed ID: 22404979
[TBL] [Abstract][Full Text] [Related]
9. The use of non-heart-beating donors for isolated pancreatic islet transplantation.
Markmann JF; Deng S; Desai NM; Huang X; Velidedeoglu E; Frank A; Liu C; Brayman KL; Lian MM; Wolf B; Bell E; Vitamaniuk M; Doliba N; Matschinsky F; Markmann E; Barker CF; Naji A
Transplantation; 2003 May; 75(9):1423-9. PubMed ID: 12792491
[TBL] [Abstract][Full Text] [Related]
10. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
11. Involvement of graft-derived interleukin-15 in islet allograft rejection in mice.
Lewis EC; Weiler M; Tejman-Yarden N; Ziv N; Mazar J; Chaimovitz C; Douvdevani A
Cytokine; 2006 Apr; 34(1-2):106-13. PubMed ID: 16723256
[TBL] [Abstract][Full Text] [Related]
12. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
Hanifi-Moghaddam P; Kappler S; Seissler J; Müller-Scholze S; Martin S; Roep BO; Strassburger K; Kolb H; Schloot NC
Diabet Med; 2006 Feb; 23(2):156-63. PubMed ID: 16433713
[TBL] [Abstract][Full Text] [Related]
13. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
14. The role of macrophage migration inhibitory factor in mouse islet transplantation.
Toso C; Serre-Beinier V; Emamaullee J; Merani S; Armanet M; Wojtusciszyn A; Bosco D; Calandra T; Roger T; Morel P; Shapiro AM; Berney T
Transplantation; 2008 Nov; 86(10):1361-9. PubMed ID: 19034004
[TBL] [Abstract][Full Text] [Related]
15. Adult porcine islets produce MCP-1 and recruit human monocytes in vitro.
Ehrnfelt C; Kumagai-Braesch M; Uzunel M; Holgersson J
Xenotransplantation; 2004 Mar; 11(2):184-94. PubMed ID: 14962280
[TBL] [Abstract][Full Text] [Related]
16. Absence of CSF-1-dependent macrophages does not improve function of transplanted islets of Langerhans.
Berney T; Molano RD; Pileggi A; Cattan P; Vizzardelli C; Ricordi C; Inverardi L
Cell Transplant; 2001; 10(7):633-7. PubMed ID: 11714198
[TBL] [Abstract][Full Text] [Related]
17. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
Emamaullee JA; Stanton L; Schur C; Shapiro AM
Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
[TBL] [Abstract][Full Text] [Related]
18. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion.
Pineau I; Sun L; Bastien D; Lacroix S
Brain Behav Immun; 2010 May; 24(4):540-53. PubMed ID: 19932745
[TBL] [Abstract][Full Text] [Related]
20. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
